Across TCGA pan-cancer cohorts, LINC01504 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of LINC01504’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where LINC01504 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01504 is over-expressed in tumor, although a few such as LUSC and LUAD show the opposite, repressed pattern.
KIRP, LUSC, and KIRC are the cancer types where LINC01504 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01504 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.